Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Stent Market to Recover With New Product Introductions: Reports Kalorama

NEW YORK, NY -- (Marketwire) -- 12/26/12 -- The global market for coronary stents is projected to recover from its recent decline due to new product innovations, exceeding $6 billion by 2017, according to a recent report from healthcare market research publisher Kalorama Information. Despite the generally difficult global economic climate and intense competition among stent manufacturers, the stent market is expected to grow in the next several years, although at a slower pace. In its new report, "The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)," Kalorama Information finds that market growth will result from an increase in the utilization of stents in interventional cardiology, fueled by a growing prevalence of coronary heart disease worldwide and the introduction of new improved devices to the market.

Several new technologies, such as bioresorbable stents, bifurcation and biodegradable polymers stents, are currently in development and projected to enter most major markets in the next years. Such new devices, especially the bioresorbable stents, have the potential to eliminate the negative issues of durable polymer stents, and are therefore expected to bring about a significant shift in the treatment of coronary heart disease, increasing the demand for stents.

"In particular, bioresorbable stents are expected to be welcomed in the treatment of coronary heart disease by both physicians and patients, substantially easing patients' discomfort of having a permanent metallic implant in their body," said analyst Adriana Rusu, author of this report.

According to the report, the first bioresorbable stent to reach the market was developed by Abbott Laboratories -- the leading player in the coronary stents market -- and launched in several markets, including Europe, in September 2012. Besides Abbott, several other companies are also developing bioresorbable stents, employing various technological approaches.

Kalorama Information's report, "The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)," examines in detail these new technologies, as well as the entire global coronary stents industry, its structure and major trends affecting it. Revenue forecasts at the global and regional level and profiles of various competitors are also included in the report.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Please direct all media inquiries to:
Bruce Carlson
Email Contact
www.KaloramaInformation.com

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterprises are u...
Just as writing has come to mean texting, blogging or any form of digital writing, the cloud today means one or all of the three Cs: computing, connectivity and communication. And just as nearly all thought to putting pen to paper has disappeared, all reference to the natural cloud is ...
Yes, Lori has been reading the Internet again. And what she’s been seeing makes baby Lori angry. It also makes this former test designer and technology editor cry. Really, I weep at both the excuses offered for such testing and the misleading headline. I have read no less than two con...
Does a Content Delivery Network (CDN) protect against Distributed Denial of Service (DDoS) attacks? It’s a good question. A CDN by its very nature will absorb DDoS attacks for the content that it serves and this could be considered protection but, as is often the case, this is only the...
The explosion of cloud onto the enterprise scene has, literally, revolutionized how businesses across the size spectrum do business, yet there’s a price tag tucked into this cloud’s silver lining that smart decision-makers should pay heed to. This is the era of what I like to call the...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE